D. C. Chambers, W. S. Cherikh, S. B. Goldfarb, D. Hayes, A. Y. Kucheryavaya et al., The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirtyfifth adult lung and heart-lung transplant report-2018; focus theme: multiorgan transplantation, J Heart Lung Transplant, vol.37, pp.1169-83, 2018.

J. Salman, F. Ius, A. K. Knoefel, W. Sommer, T. Siemeni et al., Association of higher CD4(+) CD25(high) CD127(low), FoxP3(+), and IL-2(+) T cell frequencies early after lung transplantation with less chronic lung allograft dysfunction at two years, Am J Transplant, vol.17, pp.1637-1685, 2017.

S. E. Verleden, B. M. Vanaudenaerde, M. P. Emonds, D. E. Van-raemdonck, A. P. Neyrinck et al., Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation, Eur Respir J, vol.50, p.1701248, 2017.

S. M. Studer, R. D. Levy, K. Mcneil, and J. B. Orens, Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness, Eur Respir J, vol.24, pp.674-85, 2004.

R. D. Yusen, Technology and outcomes assessment in lung transplantation, Proc Am Thorac Soc, vol.6, pp.128-164, 2009.

H. S. Kulkarni, W. S. Cherikh, D. C. Chambers, V. C. Garcia, R. R. Hachem et al., Bronchiolitis obliterans syndrome-free survival after lung transplantation: an International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis, J Heart Lung Transplant, vol.38, pp.5-16, 2019.

, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Biomarkers Definitions Working Group, vol.69, pp.89-95, 2001.

G. M. Verleden, G. Raghu, K. C. Meyer, A. R. Glanville, and P. Corris, A new classification system for chronic lung allograft dysfunction, J Heart Lung Transplant, vol.33, pp.127-160, 2014.

S. E. Verleden, D. Ruttens, E. Vandermeulen, H. Bellon, D. E. Van-raemdonck et al., Restrictive chronic lung allograft dysfunction: where are we now?, J Heart Lung Transplant, vol.34, pp.625-655, 2015.

P. J. Royer, G. Olivera-botello, A. Koutsokera, J. D. Aubert, E. Bernasconi et al., Chronic lung allograft dysfunction: a systematic review of mechanisms, Transplantation, vol.100, pp.1803-1817, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01831751

E. A. Belloli, I. Degtiar, X. Wang, G. A. Yanik, L. J. Stuckey et al., Parametric response mapping as an imaging biomarker in lung transplant recipients, Am J Respir Crit Care Med, vol.195, pp.942-52, 2017.

A. Dubbeldam, C. Barthels, J. Coolen, J. A. Verschakelen, S. E. Verleden et al., Restrictive allograft syndrome after lung transplantation: new radiological insights, Eur Radiol, vol.27, pp.2810-2817, 2017.

A. S. Siddiqui, G. Kumar, T. Majumdar, E. A. Graviss, D. T. Nguyen et al., Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients, Clin Transplant, vol.32, 2018.

M. A. Quantz, L. E. Bennett, D. M. Meyer, and R. J. Novick, Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations, J Heart Lung Transplant, vol.19, pp.473-479, 2000.

G. Opelz, C. Susal, A. Ruhenstroth, and B. Dohler, Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: a collaborative transplant study report, Transplantation, vol.90, pp.912-919, 2010.

M. Peltz, L. B. Edwards, M. E. Jessen, F. Torres, and D. M. Meyer, HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation, J Heart Lung Transplant, vol.30, pp.426-460, 2011.

D. Hayes, S. M. Black, J. D. Tobias, B. T. Kopp, S. E. Kirkby et al., Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation, J Heart Lung Transplant, vol.35, pp.186-94, 2016.

Y. Yamada, T. Langner, I. Inci, C. Benden, M. Schuurmans et al., Impact of human leukocyte antigen mismatch on lung transplant outcome, Interact Cardiovasc Thorac Surg, vol.26, pp.859-64, 2018.

O. Brugiere, G. Thabut, C. Suberbielle, M. Reynaud-gaubert, P. Thomas et al., Relative impact of human leukocyte antigen mismatching and graft ischemic time after lung transplantation, 20. van den Berg JW, vol.27, pp.368-373, 2001.

P. Huppmann, C. Neurohr, S. Leuschner, H. Leuchte, R. Baumgartner et al., The Munich-LTX-Score: predictor for survival after lung transplantation, Clin Transplant, vol.26, pp.173-83, 2012.

D. C. Walton, S. J. Hiho, L. S. Cantwell, M. B. Diviney, S. T. Wright et al., HLA matching at the eplet level protects against chronic lung allograft dysfunction, Am J Transplant, vol.16, pp.2695-703, 2016.

D. Cristofaro, J. Reynaud-gaubert, M. Carlini, F. Roubertoux, P. Loundou et al., HLA-G * 01:04 approximately UTR3 Recipient correlates with lower survival and higher frequency of chronic rejection after lung transplantation, Am J Transplant, vol.15, pp.2413-2433, 2015.

D. Cristofaro, J. Pelardy, M. Loundou, A. Basire, A. Gomez et al., HLA-E( * )01:03 Allele in Lung Transplant Recipients Correlates with Higher Chronic Lung Allograft Dysfunction Occurrence, J Immunol Res, p.1910852, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01362578

O. Brugiere, G. Thabut, I. Krawice-radanne, R. Rizzo, G. Dauriat et al., Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study, Am J Transplant, vol.15, pp.461-71, 2015.

S. M. Palmer, R. D. Davis, D. Hadjiliadis, M. I. Hertz, D. N. Howell et al., Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome, Transplantation, vol.74, pp.799-804, 2002.

D. Hadjiliadis, C. Chaparro, N. L. Reinsmoen, C. Gutierrez, L. G. Singer et al., Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study, J Heart Lung Transplant, vol.24, pp.249-54, 2005.

N. Angaswamy, D. Saini, S. Ramachandran, D. S. Nath, D. Phelan et al., Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation, Hum Immunol, vol.71, pp.560-565, 2010.

M. R. Morrell, J. M. Pilewski, C. J. Gries, M. R. Pipeling, M. M. Crespo et al., De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation, J Heart Lung Transplant, vol.33, pp.1288-94, 2014.

L. Pavec, J. Suberbielle, C. Lamrani, L. Feuillet, S. Savale et al., De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome, J Heart Lung Transplant, vol.35, pp.1067-77, 2016.

A. S. Shah, L. Nwakanma, C. Simpkins, J. Williams, D. C. Chang et al., Pretransplant panel reactive antibodies in human lung transplantation: an analysis of over 10,000 patients, Ann Thorac Surg, vol.85, pp.1919-1943, 2008.

C. L. Lau, S. M. Palmer, K. E. Posther, D. N. Howell, N. L. Reinsmoen et al., Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients, Ann Thorac Surg, vol.69, pp.1520-1524, 2000.

M. Kim, K. R. Townsend, I. G. Wood, S. Boukedes, I. Guleria et al., Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates, Am J Respir Crit Care Med, vol.189, pp.1234-1243, 2014.

J. E. Park, C. Y. Kim, M. S. Park, J. H. Song, Y. S. Kim et al., Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients, BMC Pulm Med, vol.18, p.45, 2018.

J. P. Bosanquet, C. A. Witt, B. C. Bemiss, D. E. Byers, R. D. Yusen et al., The impact of pre-transplant allosensitization on outcomes after lung transplantation, J Heart Lung Transplant, vol.34, pp.1415-1437, 2015.

K. J. Tinckam, S. Keshavjee, C. Chaparro, D. Barth, S. Azad et al., Survival in sensitized lung transplant recipients with perioperative desensitization, Am J Transplant, vol.15, pp.417-443, 2015.

L. D. Snyder, A. L. Gray, J. M. Reynolds, G. M. Arepally, A. Bedoya et al., Antibody desensitization therapy in highly sensitized lung transplant candidates, Am J Transplant, vol.14, pp.849-56, 2014.

L. J. Lobo, R. M. Aris, J. Schmitz, and I. P. Neuringer, Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation, J Heart Lung Transplant, vol.32, pp.70-77, 2013.

A. Koutsokera, P. J. Royer, J. P. Antonietti, A. Fritz, C. Benden et al., Development of a multivariate prediction model for earlyonset bronchiolitis obliterans syndrome and restrictive allograft syndrome in lung transplantation, Front Med, vol.4, p.109, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01608943

J. M. Tikkanen, L. G. Singer, S. J. Kim, Y. Li, M. Binnie et al., De novo DQ donor-specific antibodies are associated with chronic lung allograft dysfunction after lung transplantation, Am J Respir Crit Care Med, vol.194, pp.596-606, 2016.

O. Brugiere, A. Roux, L. Pavec, J. Sroussi, D. Parquin et al., Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome, Eur Respir J, vol.52, p.1701898, 2018.

D. J. Levine, A. R. Glanville, C. Aboyoun, J. Belperio, C. Benden et al., Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant, vol.35, pp.397-406, 2016.

C. M. Magro, D. M. Klinger, P. W. Adams, C. G. Orosz, A. L. Pope-harman et al., Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related, Am J Transplant, vol.3, pp.1264-72, 2003.

E. Vandermeulen, S. E. Verleden, D. Ruttens, E. Moelants, A. Mortier et al., BAL neutrophilia in azithromycin-treated lung transplant recipients: clinical significance, Transpl Immunol, vol.33, pp.37-44, 2015.

E. Vandermeulen, E. Lammertyn, S. E. Verleden, D. Ruttens, H. Bellon et al., Immunological diversity in phenotypes of chronic lung allograft dysfunction: a comprehensive immunohistochemical analysis, Transpl Int, vol.30, pp.134-177, 2017.

R. R. Hachem, V. Tiriveedhi, G. A. Patterson, A. Aloush, E. P. Trulock et al., Antibodies to K-alpha 1 tubulin and collagen V are associated with chronic rejection after lung transplantation, Am J Transplant, vol.12, pp.2164-71, 2012.

D. Saini, J. Weber, S. Ramachandran, D. Phelan, V. Tiriveedhi et al., Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts

, J Heart Lung Transplant, vol.30, pp.624-655, 2011.

K. J. Patel, Q. Cheng, S. Stephenson, D. P. Allen, C. Li et al., Emphysema associated autoreactive antibodies exacerbate post lung transplant ischemia reperfusion injury, Am J Respir Cell Mol Biol, vol.60, pp.678-86, 2018.

U. Rao, M. Sharma, T. Mohanakumar, C. Ahn, A. Gao et al., Prevalence of antibodies to lung self-antigens. (Kalpha1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: single center experience, Transpl Immunol, vol.54, pp.65-72, 2019.

V. Tiriveedhi, B. Gautam, N. J. Sarma, M. Askar, M. Budev et al., Pre-transplant antibodies to Kalpha1 tubulin and collagen-V in lung transplantation: clinical correlations, J Heart Lung Transplant, vol.32, pp.807-821, 2013.

F. Meloni, P. Vitulo, A. M. Bianco, E. Paschetto, M. Morosini et al., Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome, Transplantation, vol.77, pp.762-768, 2004.

D. Piloni, M. Morosini, S. Magni, A. Balderacchi, L. Scudeller et al., Analysis of long term CD4+CD25highCD127-T-reg cells kinetics in peripheral blood of lung transplant recipients, BMC Pulm Med, vol.17, p.102, 2017.

M. Durand, P. Lacoste, R. Danger, L. Jacquemont, C. Brosseau et al., High circulating CD4(+)CD25(hi)FOXP3(+) T-cell subpopulation early after lung transplantation is associated with development of bronchiolitis obliterans syndrome, J Heart Lung Transplant, vol.37, pp.770-81, 2018.

E. Mamessier, A. M. Lorec, P. Thomas, M. Badier, A. Magnan et al., T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome, vol.84, pp.908-924, 2007.

S. M. Bhorade, H. Chen, L. Molinero, C. Liao, E. R. Garrity et al., Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome, Transplantation, vol.90, pp.540-546, 2010.

K. Budding, E. A. Van-de-graaf, A. W. Paantjens, T. Kardol-hoefnagel, J. M. Kwakkel-van-erp et al., Profiling of peripheral blood mononuclear cells does not accurately predict the bronchiolitis obliterans syndrome after lung transplantation, Transpl Immunol, vol.32, pp.195-200, 2015.

E. Vandermeulen, S. E. Verleden, H. Bellon, D. Ruttens, E. Lammertyn et al., Humoral immunity in phenotypes of chronic lung allograft dysfunction: a broncho-alveolar lavage fluid analysis, Transpl Immunol, vol.38, pp.27-32, 2016.

B. M. Vanaudenaerde, D. Vleeschauwer, S. I. Vos, R. Meyts, I. Bullens et al., The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation, Am J Transplant, vol.8, pp.1911-1931, 2008.

C. Neurohr, P. Huppmann, B. Samweber, S. Leuschner, G. Zimmermann et al., Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients, J Heart Lung Transplant, vol.28, pp.468-74, 2009.

R. Danger, B. Sawitzki, and S. Brouard, Immune monitoring in renal transplantation: the search for biomarkers, Eur J Immunol, vol.46, pp.2695-704, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02150158

V. Tiriveedhi, M. Takenaka, S. Ramachandran, A. E. Gelman, V. Subramanian et al., T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease

, Am J Transplant, vol.12, pp.2663-74, 2012.

A. L. Gregson, A. Hoji, V. Palchevskiy, S. Hu, S. S. Weigt et al., Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA-T regulatory cells, PLoS ONE, vol.5, 2010.

D. Krustrup, M. Iversen, T. Martinussen, H. H. Schultz, and C. B. Andersen, The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation, Clin Transplant, vol.29, pp.179-84, 2015.

P. M. Fisichella, C. S. Davis, E. Lowery, L. Ramirez, R. L. Gamelli et al., Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation, J Am Coll Surg, vol.217, 2013.

M. Y. Shino, S. S. Weigt, N. Li, V. Palchevskiy, A. Derhovanessian et al., The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation, PLoS ONE, vol.12, p.180281, 2017.

K. Budding, E. A. Van-de-graaf, T. Kardol-hoefnagel, J. M. Kwakkel-van-erp, B. D. Luijk et al., Soluble CD59 is a novel biomarker for the prediction of obstructive chronic lung allograft dysfunction after lung transplantation, Sci Rep, vol.6, p.26274, 2016.

J. Zou, B. Duffy, M. Slade, A. L. Young, N. Steward et al., Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch, Hum Immunol, vol.78, pp.342-351, 2017.

S. Agbor-enoh, A. M. Jackson, I. Tunc, G. J. Berry, A. Cochrane et al., Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: evidence from cell-free DNA analysis, J Heart Lung Transplant, vol.37, pp.925-957, 2018.

M. Gunasekaran, Z. Xu, D. K. Nayak, M. Sharma, R. Hachem et al., Donor-derived exosomes with lung self-antigens in human lung allograft rejection, Am J Transplant, vol.17, pp.474-84, 2017.

R. Danger, C. Paul, M. Giral, A. Lavault, Y. Foucher et al., Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection, PLoS ONE, vol.8, p.60702, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02165884

M. Pain, P. J. Royer, J. Loy, A. Girardeau, A. Tissot et al., T cells promote bronchial epithelial cell secretion of matrix metalloproteinase-9 via a C-C chemokine receptor type 2 pathway: implications for chronic lung allograft dysfunction, Am J Transplant, vol.17, pp.1502-1516, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01573742

E. A. Kastelijn, C. H. Van-moorsel, H. J. Ruven, N. M. Korthagen, J. M. Kwakkel-van-erp et al., YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome, Sarcoidosis Vasc Diffuse Lung Dis, vol.30, pp.28-35, 2013.

A. M. Ramirez, D. R. Nunley, M. Rojas, and J. Roman, Activation of tissue remodeling precedes obliterative bronchiolitis in lung transplant recipients, Biomark Insights, vol.3, pp.351-360, 2008.

P. Jaksch, S. Taghavi, W. Klepetko, and M. Salama, Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients, J Thorac Cardiovasc Surg, vol.148, pp.273-81, 2014.

R. Danger, P. J. Royer, D. Reboulleau, E. Durand, J. Loy et al., Blood gene expression predicts bronchiolitis obliterans syndrome. Front Immunol, vol.8, p.1841, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01832982

S. S. Weigt, X. Wang, V. Palchevskiy, A. L. Gregson, N. Patel et al., Gene expression profiling of bronchoalveolar lavage cells preceding a clinical diagnosis of chronic lung allograft dysfunction, PLoS ONE, vol.12, 2017.

A. Sacreas, J. Yang, B. M. Vanaudenaerde, T. K. Sigdel, J. M. Liberto et al., The common rejection module in chronic rejection post lung transplantation, PLoS ONE, vol.13, p.205107, 2018.

P. Khatri, S. Roedder, N. Kimura, D. Vusser, K. Morgan et al., A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation, J Exp Med, vol.210, pp.2205-2226, 2013.

D. Jonigk, N. Izykowski, J. Rische, P. Braubach, M. Kuhnel et al., Molecular profiling in lung biopsies of human pulmonary allografts to predict chronic lung allograft dysfunction, Am J Pathol, vol.185, pp.3178-88, 2015.

K. Budding, M. Rossato, E. A. Van-de-graaf, J. M. Kwakkel-van-erp, T. Radstake et al., Serum miRNAs as potential biomarkers for the bronchiolitis obliterans syndrome after lung transplantation, Transpl Immunol, vol.42, pp.1-4, 2017.

M. Benmerad, R. Slama, K. Botturi, J. Claustre, A. Roux et al., Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study
URL : https://hal.archives-ouvertes.fr/hal-01521358

, Eur Respir J, vol.49, p.1600206, 2017.

D. Ruttens, S. E. Verleden, P. C. Goeminne, K. Poels, E. Vandermeulen et al., Smoking resumption after lung transplantation: standardised screening and importance for long-term outcome, Eur Respir J, vol.43, pp.300-303, 2014.

N. Drick, B. Seeliger, J. Fuge, I. Tudorache, M. Greer et al., Selfreported non-adherence to immunosuppressivemedication in adult lung transplant recipients-A single-center cross-sectional study, Clin Transplant, vol.32, 2018.